GOLDENWELL BIOTECH, INC. GWLL
OTC · stock · Food and Kindred Products · website · IPO 2021-12-07
GOLDENWELL BIOTECH, INC. (GWLL) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2024 revenue was $139 at a -94602.9% net margin.
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$51M
Net margin-94602.9%
Revenue trend · last 6y · up
How it ranks in Manufacturing · percentile among 1906 companies
Piotroski Fstronger than 27%
Net marginstronger than 1%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| GWLL | GOLDENWELL BIOTECH, INC. | 3/9 | — | — | — |
| SOWG | Sow Good Inc. | 1/9 | — | — | — |
| TRWD | Tradewinds Universal | 3/9 | — | — | — |
| NXMH | Next Meats Holdings, Inc. | 1/9 | — | — | — |
| BOF | BranchOut Food Inc. | 3/9 | -7.44 | — | — |
| CHSN | Chanson International Holding | 4/9 | 1.92 | 20.4 | +0.2% |
| BRLS | Borealis Foods Inc. | 4/9 | -16.21 | — | +8.2% |
FAQ
Is GWLL financially healthy?
GOLDENWELL BIOTECH, INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does GWLL pay a dividend?
No, GOLDENWELL BIOTECH, INC. does not currently pay a dividend.
How profitable is GWLL?
In FY2024, GOLDENWELL BIOTECH, INC. had a net margin of -94602.9%.
Source: SEC EDGAR filings · CIK 0001800373 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.